Vihaan D. Gupta*
Polymorphism, the genetic phenomenon where a single gene manifests in multiple forms, has long been a subject of scientific intrigue. In the context of the COVID-19 pandemic, understanding how genetic variations contribute to symptomatic susceptibility is crucial for devising effective public health strategies. This article delves into the concept of polymorphism and its implications in determining the severity of COVID-19 symptoms. By examining recent research findings and genetic studies, we unravel the intricate relationship between polymorphism and susceptibility to symptomatic COVID-19.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 